Psychiatric symptoms in patients with metastatic ALK-positive NSCLC treated with third-generation ALK-inhibitors: a brief review and case series (A. Pagliaro, S. Rossi, A. Santoro, & L. Toschi , Trans.). (2024). Journal of Medical Science, 93(3), e986. https://doi.org/10.20883/medical.e986